Multinational drug firms’ revenues fall 3% on slump

Published: 2013-04-15 07:00:00

Updated: 2013-04-15 07:00:00

Twenty-six multinational drug makers saw their combined sales drop 2.6 percent in 2012 from a year earlier, an online pharmaceutical information provider said Friday, pointing to their troubles stemming from the government-mandated price cut for drugs in April of last year.

The combined sales ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK